The only direct, swift and accurate way to measure total blood volume and red blood cell volume in the clinical setting

Read More

Key Features

  • Actionable results with 98% accuracy
  • Quantifies the excess or deficit vs patient-specific ideal
  • Non-invasive, single-venipuncture technique

Latest News

Daxor Corporation Announces Delay in Filing of Form N-CSR for December 31, 2016, and the Uniformed Services University of Health Sciences has been awarded a grant to study hemodilution utilizing Daxor’s BVA-100 device

NEW YORK, NY–(Marketwired – Apr 10, 2017) – On April 10, 2017, Daxor Corporation (NYSE MKT: DXR) received a letter from the NYSE MKT LLC (“the Exchange”) noting that it is not in compliance with the listing standards pertaining to the timing of SEC filings as set forth in Sections 134 and 1101 of the […]

Read More

Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor the Daxor BVA-100 Device, Dr. Joseph Feldschuh

New York, NY February 1, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, sadly announced today the death of the Company’s founder and its first President and Chief Executive Officer, Dr. Joseph Feldschuh. Dr Feldschuh, who was working on a part-time basis and responding well treatment for […]

Read More